MyFinsight
Home
Blog
About
Contact
Download
Download image
Accrued trade discounts
and rebates
$6,256K
Accounts payable
$4,250K
Stock-based compensation
$4,140K
Amortization of intangible
assets
$2,710K
Net income (loss)
$2,234K
Amortization of debt discount
and debt issuance...
$889K
Inventory
-$851K
Depreciation
$337K
Amortization of operating
right-of-use assets
$163K
Prepaid expenses and
other current assets
-$145K
Net cash provided by
(used in) operating...
$9,870K
Canceled cashflow
$12,105K
Net increase
(decrease) in cash, cash...
$708K
Canceled cashflow
$9,162K
Trade accounts
receivable
$5,245K
Other
-$4,683K
Other accrued
liabilities
-$1,497K
Operating lease
liabilities
-$434K
Accrued returns reserve
-$246K
Proceeds from issuance of
warrants
$7,333K
Proceeds from exercise of
stock options
$847K
Net cash used in
financing activities
-$8,837K
Net cash used in
investing activities
-$325K
Canceled cashflow
$8,180K
Repurchase of common stock
withheld for taxes
$17,017K
Capital expenditures
-$325K
Back
Back
Cash Flow
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS)
source: myfinsight.com